Virginia Tech researchers develop new drug design framework

As the COVID-19 pandemic scattered and isolated people, researchers across Virginia Tech connected for a data-driven collaboration seeking improved drugs to fight the disease and potentially many other illnesses.

Related Keywords

Virginia , United States , Maryland , Sanketa Deshmukh , Lakshmi Kumar Kunche , Soumily Joshi , Annem Brown , Samrendrak Singh , Andrew Lowell , Kelsie King , Parisa Farzeen , Emilym Webb , Christina Chuong , Cole Gannett , Megan Craig , James Weger Lucarelli , Life Sciences , Department Of Biochemistry , Department Of Biomedical Sciences , College Of Science , Maryland College Of Veterinary Medicine , College Of Engineering , College Of Agriculture , University Libraries , Department Of Chemistry , Virginia Tech , Driven Computational Design , Experimental Validation , Accelerated Mitigation , Pandemic Like Scenarios , Physical Chemistry , Biomedical Sciences , Virginia Maryland College , Veterinary Medicine , Charles Plate , Covid 19 , Drugs , Compound , Nzyme , Laboratory , Olecule , Pandemic , Protein , Sample Preparation , Cars , Ars Cov 2 , Small Molecules , Students , Veterinary , Virus ,